<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To assess the role of <z:chebi fb="95" ids="16301">nitrite</z:chebi> (<z:chebi fb="0" ids="29272">NO(2)</z:chebi>(-)), nitrate (NO(3)(-)), and nitrative stress in thrombotic <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: We investigated 46 patients with PAPS: 21 asymptomatic but persistent carriers of <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (PCaPL), 38 patients with inherited <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> (IT), 33 patients with <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE), and 29 healthy controls (CTR) </plain></SENT>
<SENT sid="2" pm="."><plain>IgG anticardiolipin (aCL), IgG anti-beta(2)-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (anti-ÃŸ(2)-GPI), IgG anti-<z:chebi fb="6" ids="39025">high density lipoprotein</z:chebi> (aHDL), IgG anti-<z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> A-I (aApoA-I), crude nitrotyrosine (NT) (an indicator of nitrative stress), and high sensitivity C-reactive protein (CRP) were measured by immunoassays </plain></SENT>
<SENT sid="3" pm="."><plain>Plasma <z:chebi fb="95" ids="16301">nitrite</z:chebi> (<z:chebi fb="0" ids="29272">NO(2)</z:chebi>(-)), nitrate (NO(3)(-)), and total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> capacity (<z:chebi fb="44" ids="53498">TAC</z:chebi>) were measured by colorimetric spectroscopic assays </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Average plasma <z:chebi fb="0" ids="29272">NO(2)</z:chebi>(-) was lower in PAPS, PCaPL, and IT (p &lt; 0.0001); average NO(3)(-) was highest in SLE (p &lt; 0.0001), whereas average NT was higher in PAPS and SLE (p = 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>In thrombotic PAPS, IgG aCL titer and number of <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e> negatively predicted <z:chebi fb="0" ids="29272">NO(2)</z:chebi>(-) (p = 0.03 and p = 0.001, respectively), whereas <z:mp ids='MP_0006134'>arterial occlusions</z:mp> and smoking positively predicted NO(3)(-) (p = 0.05 and p = 0.005), and CRP positively predicted NT (p = 0.004) </plain></SENT>
<SENT sid="6" pm="."><plain>In the PCaPL group IgG aCL negatively predicted NO(3)(-) (p = 0.03) </plain></SENT>
<SENT sid="7" pm="."><plain>In the SLE group IgG aCL negatively predicted <z:chebi fb="0" ids="29272">NO(2)</z:chebi>(-) (p = 0.03) and NO(3)(-) (p = 0.02) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: PAPS is characterized by decreased <z:chebi fb="0" ids="29272">NO(2)</z:chebi>(-) in relation to type and number of <z:e sem="disease" ids="C1096458" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">vascular occlusions</z:e> and to aPL titers </plain></SENT>
<SENT sid="9" pm="."><plain>Nitrative stress and low grade <z:mp ids='MP_0001845'>inflammation</z:mp> are linked phenomena in PAPS and may have implications for <z:mp ids='MP_0005048'>thrombosis</z:mp> and <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> </plain></SENT>
</text></document>